| Douglas Edward Merz, PT | |
|
15000 Minnetonka Blvd, Minnetonka, MN 55345-1506 | |
| (952) 935-4037 | |
| Not Available |
| Full Name | Douglas Edward Merz |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 39 Years |
| Location | 15000 Minnetonka Blvd, Minnetonka, Minnesota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013062165 | NPI | - | NPPES |
| 6B480ME | Other | MN | BLUE CROSS INDIVIDUAL ID |
| 1024610 | Other | MN | PREFERRED ONE GROUP # |
| 6B478OR | Other | MN | BLUE CROSS BLUE SHIELD GR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2916 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Merz, Inc. | 3173418456 | 3 |
News Archive
The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.
The eyes may be the window to the soul, but to scientists, they are also the window to the brain. In particular, the retina, a delicate light-sensing neural network with specialized cells at the back of the eyeball, is linked directly to the brain via the optic nerve and is considered by some to be part of the brain itself.
According to new research, dieters who binge before bedtime could hold the key to weight loss.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
› Verified 1 days ago
| Provider Name | Merz, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932253473 PECOS PAC ID: 3173418456 Enrollment ID: O20040226000406 |
News Archive
The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.
The eyes may be the window to the soul, but to scientists, they are also the window to the brain. In particular, the retina, a delicate light-sensing neural network with specialized cells at the back of the eyeball, is linked directly to the brain via the optic nerve and is considered by some to be part of the brain itself.
According to new research, dieters who binge before bedtime could hold the key to weight loss.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Edward Merz, PT 15000 Minnetonka Blvd, Minnetonka, MN 55345-1506 Ph: (952) 935-4037 | Douglas Edward Merz, PT 15000 Minnetonka Blvd, Minnetonka, MN 55345-1506 Ph: (952) 935-4037 |
News Archive
The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.
The eyes may be the window to the soul, but to scientists, they are also the window to the brain. In particular, the retina, a delicate light-sensing neural network with specialized cells at the back of the eyeball, is linked directly to the brain via the optic nerve and is considered by some to be part of the brain itself.
According to new research, dieters who binge before bedtime could hold the key to weight loss.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
› Verified 1 days ago
Lisa Nelezen, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2713 Autumnwood Ln, Minnetonka, MN 55305 Phone: 952-593-1592 | |
Tanya Kohnen, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15111 Twelve Oaks Center Dr, Minnetonka, MN 55305 Phone: 952-993-4500 | |
Katherine H Shearer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3395 Plymouth Rd, St David's Center, Minnetonka, MN 55305 Phone: 952-939-0396 Fax: 952-548-8760 | |
Kristin L Brastad, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5959 Baker Rd Ste 340, Minnetonka, MN 55345 Phone: 651-348-7428 Fax: 651-348-7432 | |
Ann Johnson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3836 Oak Rd, Minnetonka, MN 55345 Phone: 952-931-9033 | |
Ms. Nancy Lou Appel, PT MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10721 Smetana Rd, Suite L20, Minnetonka, MN 55343 Phone: 952-936-9215 Fax: 952-936-9942 |